This week, Prolacta Bioscience announced a new clinical study just published by the Journal of Pediatrics clearly demonstrating that 100% exclusive human milk based diet for pre-term infants reduces chances of surgery associated with the life threatening disease necrotizing enterocolitis (NEC). This reinforces a study in 2009 and points to a new standard of care for these infants.
Even with this compelling and reaffirmed evidence, only about a third of the Neonatal Intensive Care Units (NICUs) in the U.S. have ensured that severely premature infants receive an exclusively human milk diet; including fortifier (HMF) supplements required by these patients with stomachs the size of a quarter. What could be the long-term effects of not being fed breast milk as a preemie in the NICU?
With this primary research in the advancement of the science of human milk, PilmerPR client Prolacta is improving the standard of nutrition in hospital NICUs where cow milk fortifier has been the only option. Prolacta’s human milk fortifier (HMF) is the only HMF made exclusively from human milk and significantly reduces the risk of NEC.
“These results are not surprising” said Scott Elster CEO of Prolacta Bioscience. “They simply reinforce the results of the previous randomized clinical trial and the experience of our customers. There are approximately 40000 babies born each year weighing less than 2 lbs 12 ounces. These babies would fit in the palm of your hand. They are fed through a tube and spend the first 70-90 days of their life in the neonatal intensive care unit. These babies should be fed an exclusive human milk diet and this study clearly demonstrates that fact.”
Prolacta Donation to International Breast Milk Project (IBMP)Share